ENTRY       D04036                      Drug
NAME        Epratuzumab (USAN/INN);
            Lymphocide (TN)
EFFICACY    Antineoplastic, Anti-CD22 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of non-Hodgkin's B-cell lymphomas
TARGET      CD22 (SIGLEC2) [HSA:933] [KO:K06467]
  PATHWAY   hsa04514(933)  Cell adhesion molecules
            hsa04640(933)  Hematopoietic cell lineage
            hsa04662(933)  B cell receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               SIGLEC family
                CD22 (SIGLEC2)
                 D04036  Epratuzumab (USAN/INN)
DBLINKS     CAS: 205923-57-5
            PubChem: 47206001
            NIKKAJI: J2.313.544B
///
